SCHEMBL6558702

SCHEMBL6558702

CCS(=O)(=O)N(CCCC(F)(F)F)C1CC2(CCCC2)Oc2ccc(F)cc21

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KCNE1 P15382 6/20 0.40
KCNQ1 P51787 6/20 0.40
TRPV1 Q8NER1 11/20 0.38
DPP4 P27487 2/20 0.36
DPP7 Q9UHL4 2/20 0.36
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561028 0.99 KCNE1 (0.40) KCNE1KCNQ1TRPV1DPP4DPP7
SCHEMBL6559250 0.87 KCNE1 (0.44) KCNE1KCNQ1TRPV1DPP4DPP7
SCHEMBL6559570 0.81 KCNE1 (0.55) KCNE1KCNQ1TRPV1
SCHEMBL6560981 0.80 KCNE1 (0.54) KCNE1KCNQ1TRPV1
SCHEMBL6558722 0.78 KCNE1 (0.48) KCNE1KCNQ1TRPV1
SCHEMBL6558683 0.78 KCNE1 (0.36) KCNE1KCNQ1DPP4DPP7KCNH2
SCHEMBL6559549 0.77 KCNE1 (0.36) KCNE1KCNQ1TRPV1DPP4DPP7
SCHEMBL7826231 0.75 KCNE1 (0.36) KCNE1KCNQ1KCNH2
SCHEMBL6558719 0.75 KCNE1 (0.46) KCNE1KCNQ1KCNH2
SCHEMBL6560826 0.75 HTR2B (0.35) KCNE1KCNQ1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed